Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mária Zvaríková
Observed names:
M Zvaríková,
Maria Zvarikova
Institutions:
Masaryk University,
Masaryk Memorial Cancer Institute
Observed institutions:
Masaryk University,
Masaryk Memorial Cancer Institute
OpenAlex ID:
A5023636557
Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence
2021
·
Milos Holanek
, Iveta Selingerova
, et al.
·
Cancers
·
37
PDF
Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy
2022
·
Milos Holanek
, Iveta Selingerova
, et al.
·
Diagnostics
·
8
PDF
Uncommon EGFR Mutations in Non-Small Cell Lung Cancer and Their Impact on the Treatment
2019
·
Ondřej Bílek
, Miloš Holánek
, et al.
·
Klinicka onkologie
·
7
PDF
Effectiveness of Neoadjuvant Therapy with Platinum-Based Agents for Patients with BRCA1 and BRCA2 Germline Mutations – A Retrospective Analysis of Breast Cancer Patients Treated at MMCI Brno
2019
·
Miloš Holánek
, Ondřej Bílek
, et al.
·
Klinicka onkologie
·
7
PDF
Extraoseus Ewing‘s Sarcoma, Primary Affection of Uterine Cervix – Case Report
2015
·
Ondřej Bílek
, Miloš Holánek
, et al.
·
Klinicka onkologie
·
6
PDF
Meigs’ syndrom
2022
·
Lenka Kristková
, Mária Zvaríková
, et al.
·
Klinicka onkologie
·
3
PDF
Reactive Lymphoid Hyperplasia of the Liver
2017
·
Barbora Dobiášová
, Mária Zvaríková
, et al.
·
Klinicka onkologie
·
2
ATHENA-MONO Post-Progression Survival Data Update In Patients With Newly Diagnosed Advanced Ovarian Cancer
2025
·
Sharad Ghamande
, Rowan E. Miller
, et al.
·
International Journal of Gynecological Cancer
PDF
Méně časté mutace EGFR v kontextu léčby nemalobuněčného karcinomu plic
2019
·
Ondřej Bílek
, Miloš Holánek
, et al.
Gynekologické zhoubné nádory
2015
·
Luboš Minář
, Mária Zvaríková
[Comparison of pegylated liposomal doxorubicin and carboplatin with paclitaxel and carboplatin in the treatment of patients with late recurrence of platin-sensitive ovarian carcinoma].
2011
·
M Zvaríková
·
PubMed
[Trabectedin registry].
2011
·
K Kubácková
, J Fínek
, et al.
·
PubMed
Retrospektivní analýza pacientů hospitalizovaných pro febrilníneutropenii. Vyžadují pacienti se solidními tumory specifickýpřístup v profylaxi a v léčbě febrilní neutropenie
2008
·
Marek Svoboda
, Jiří Navrátil
, et al.
Importance of Monitoring the Quality of Care of Patients withFebrile Neutropenia
2007
·
Marek Svoboda
, Miloš Holánek
, et al.
Je použití lithia k profylaxi a k léčbě chemoterapií indukovanéneutropenie opodstatněné a bez rizika? Klinicko-experimentálnístudie.
2006
·
Marek Svoboda
, Marián Hajdúch
, et al.
·
Klinicka onkologie
Show more works
View as search
Works count:
15
Citation count:
70
H-index:
5
I10-index:
1
Year
Topic
Type
